1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

Applying for mesothelioma research funding through the CDMRP’s PRCRP

Rare Cancers Research Program

Since 2008, the Department of Defense has funded mesothelioma research through its Congressionally Directed Medical Research Program – more specifically, through the Peer Reviewed Cancer Research Program (PRCRP). The PRCRP appropriation of $115,000,000 will be allocated toward 20 topic areas, including mesothelioma. To date, mesothelioma investigators have received over $20 million in awards to advance their research. Thanks to advocacy by the Foundation, mesothelioma was added as an eligible topic area for funding in 2008. The Foundation advocates annually for its continued inclusion. All mechanisms of funding within the program are now open and accepting applications for Fiscal Year 2021.

Learn more about this funding program: https://cdmrp.army.mil/funding/prcrp

We were recently joined by Donna Kimbark, PhD, program manager for the Peer Reviewed Cancer Research Program (PRCRP) at the Congressionally Directed Medical Research Programs (CDMRP). Dr. Kimbark provided an overview of the application process for mesothelioma research funding and strategies for success for mesothelioma researchers who wish to apply for this funding.

Watch the video

The Mesothelioma Applied Research Foundation is the only 501(c)(3) nonprofit organization working to eradicate mesothelioma and end this national tragedy. Its programs include the funding of promising and peer-reviewed research, education, support and advocacy. The organization strives to bring together thought leaders in the field to identify the most direct path to a cure.

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn